LYTENAVA Trademark

Trademark Overview

On Thursday, September 14, 2023, a trademark application was filed for LYTENAVA with the United States Patent and Trademark Office. The USPTO has given the LYTENAVA trademark a serial number of 98180421. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Tuesday, October 14, 2025. This trademark is owned by Outlook Therapeutics, Inc.. The LYTENAVA trademark is filed in the Pharmaceutical Products category with the following description:

Injectable pharmaceutical preparations for the treatment of retinal disease; pharmaceuticals, namely, ophthalmic drugs for the treatment of retinal disease

General Information

Serial Number98180421
Word MarkLYTENAVA
Filing DateThursday, September 14, 2023
Status731 - SECOND EXTENSION - GRANTED
Status DateTuesday, October 14, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 3, 2024

Trademark Statements

Goods and ServicesInjectable pharmaceutical preparations for the treatment of retinal disease; pharmaceuticals, namely, ophthalmic drugs for the treatment of retinal disease

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 3, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOutlook Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIselin, NJ 08830
US
Party NameOutlook Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIselin, NJ 08830
US

Trademark Events

Event DateEvent Description
Monday, September 18, 2023NEW APPLICATION ENTERED
Tuesday, October 3, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 8, 2024ASSIGNED TO EXAMINER
Tuesday, May 14, 2024NON-FINAL ACTION WRITTEN
Tuesday, May 14, 2024NON-FINAL ACTION E-MAILED
Tuesday, May 14, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, July 26, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 14, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 3, 2024PUBLISHED FOR OPPOSITION
Tuesday, September 3, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 29, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, March 19, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 19, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 19, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 19, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, April 10, 2025SOU TEAS EXTENSION RECEIVED
Thursday, April 10, 2025SOU EXTENSION 1 FILED
Thursday, April 10, 2025SOU EXTENSION 1 GRANTED
Friday, April 11, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 14, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, October 14, 2025SOU EXTENSION 2 FILED
Tuesday, October 14, 2025SOU EXTENSION 2 GRANTED
Wednesday, October 15, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 20, 2026TEAS STATEMENT OF USE RECEIVED
Monday, April 20, 2026SOU TEAS EXTENSION RECEIVED

Related Keywords

lytenava disease treatment retinal ophthalmic drugs namely pharmaceuticals injectable pharmaceutical preparations